<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">nnp</journal-id><journal-title-group><journal-title xml:lang="en">Neurology, Neuropsychiatry, Psychosomatics</journal-title><trans-title-group xml:lang="ru"><trans-title>Неврология, нейропсихиатрия, психосоматика</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2074-2711</issn><issn pub-type="epub">2310-1342</issn><publisher><publisher-name>"IMA-Press", LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.14412/2074-2711-2024-6-112-117</article-id><article-id custom-type="elpub" pub-id-type="custom">nnp-2427</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>REVIEWS</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОБЗОРЫ</subject></subj-group></article-categories><title-group><article-title>Comorbid disorders and their possible prevention in patients with vestibular vertigo</article-title><trans-title-group xml:lang="ru"><trans-title>Коморбидные расстройства и их возможная профилактика у пациентов с вестибулярным головокружением</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5827-9428</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Косивцова</surname><given-names>О. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Kosivtsova</surname><given-names>O. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p> 119021, Москва, ул. Россолимо, 11, стр. 1 </p></bio><bio xml:lang="en"><p> 11, Rossolimo St., Build. 1, Moscow 119021 </p></bio><email xlink:type="simple">o.kosivtsova@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6624-5500</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Старчина</surname><given-names>Ю. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Starchina</surname><given-names>Yu. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p> 119021, Москва, ул. Россолимо, 11, стр. 1 </p></bio><bio xml:lang="en"><p> 11, Rossolimo St., Build. 1, Moscow 119021 </p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шоев</surname><given-names>Б. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Shoev</surname><given-names>B. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p> 119021, Москва, ул. Россолимо, 11, стр. 1 </p></bio><bio xml:lang="en"><p> 11, Rossolimo St., Build. 1, Moscow 119021 </p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Кафедра нервных болезней и нейрохирургии Института клинической медицины им. Н.В. Склифосовского ФГАОУ ВО «Первый Московский государственный медицинский университет им. И.М. Сеченова» (Сеченовский Университет) Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Department of Nervous Diseases and Neurosurgery, N.V. Sklifosovsky Institute of Clinical Medicine, I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2024</year></pub-date><pub-date pub-type="epub"><day>18</day><month>12</month><year>2024</year></pub-date><volume>16</volume><issue>6</issue><fpage>112</fpage><lpage>117</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Kosivtsova O.V., Starchina Y.A., Shoev B.A., 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="ru">Косивцова О.В., Старчина Ю.А., Шоев Б.А.</copyright-holder><copyright-holder xml:lang="en">Kosivtsova O.V., Starchina Y.A., Shoev B.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://nnp.ima-press.net/nnp/article/view/2427">https://nnp.ima-press.net/nnp/article/view/2427</self-uri><abstract><p>Acute vestibular vertigo (AVV) is manifested by the illusion of movement of surrounding objects in front of the eyes or the sensation of movement of one's own body in space. The cause of AVV is in most cases a pathology of the peripheral vestibular analyser, in rarer cases – involvement of the brain stem. Headaches, neck pain, anxiety-depressive disorders, unsteadiness when walking, reduced cognitive abilities and general weakness often complicate AVV, significantly impair quality of life and slow down recovery. Treatment of patients with AVV should include rapid relief of an acute attack to prevent the development of these symptoms, increase patient compliance with vestibular rehabilitation and reduce the risk of developing anxiety-depressive syndrome. As a drug therapy for AVV, a fixed combination of dimenhydrinate and cinnarizine (Arlevert) is effective; it has a minimal sedative effect compared to other vestibular blockers and helps to rapidly reduce the intensity of dizziness and vegetative symptoms. Vestibular gymnastics promotes the processes of natural habituation, reduces the severity of instability and the risk of falling and increases motor activity. All patients with dizziness should have their mental state assessed and existing disorders corrected in collaboration with psychiatrists and cognitive behavioural therapists.</p></abstract><trans-abstract xml:lang="ru"><p>Острое вестибулярное головокружение (ОВГ) проявляется иллюзией движения перед глазами или ощущением движения собственного тела вокруг окружающих предметов. Причиной ОВГ в большинстве случаев является патология периферического вестибулярного анализатора, в более редких случаях – повреждение ствола головного мозга. Головная боль, боль в области шеи, тревожно-депрессивные расстройства, неустойчивость при ходьбе, снижение когнитивных способностей, общая слабость часто осложняют ОВГ, значительно снижают качество жизни, замедляют выздоровление. Ведение пациентов с ОВГ должно включать быстрое купирование острого приступа, что позволит предотвратить развитие данных симптомов, повысить приверженность пациентов вестибулярной реабилитации и снизить риск развития тревожно-депрессивного синдрома. В качестве лекарственной терапии ОВГ эффективна фиксированная комбинация дименгидрината и циннаризина (Арлеверт), которая обладает минимальным седативным эффектом по сравнению с другими вестибулолитическими препаратами и помогает быстро уменьшить интенсивность головокружения и вегетативных симптомов. Вестибулярная гимнастика способствует процессам естественной габитуации, уменьшает выраженность неустойчивости и снижает риск падений, увеличивает двигательную активность. У всех пациентов с головокружением необходимо оценивать психическое состояние и проводить коррекцию имеющихся расстройств совместно с психиатрами и специалистами по когнитивно-поведенческой терапии.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>головокружение</kwd><kwd>лечение</kwd><kwd>боль в шее</kwd><kwd>неустойчивость</kwd><kwd>тревожно-депрессивный синдром</kwd><kwd>вестибулосупрессивная терапия</kwd><kwd>доброкачественное пароксизмальное позиционное головокружение</kwd><kwd>болезнь (синдром) Меньера</kwd><kwd>вестибулярный нейронит</kwd><kwd>дименгидринат</kwd><kwd>циннаризин</kwd><kwd>Арлеверт</kwd><kwd>вестибулярная реабилитация</kwd></kwd-group><kwd-group xml:lang="en"><kwd>dizziness</kwd><kwd>treatment</kwd><kwd>neck pain</kwd><kwd>instability</kwd><kwd>anxiety-depressive syndrome</kwd><kwd>vestibular suppressive therapy</kwd><kwd>benign paroxysmal positional vertigo</kwd><kwd>Meniere's disease (syndrome)</kwd><kwd>vestibular neuronitis</kwd><kwd>dimenhydrinate</kwd><kwd>cinnarizine</kwd><kwd>Arlevert</kwd><kwd>vestibular rehabilitation</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Косивцова ОВ, Старчина ЮА, Уртенов КА, Белкина ВВ. Головокружение у пожилых пациентов: обсуждение на примере клинического наблюдения. Неврология, нейропсихиатрия, психосоматика. 2024;16(4):85-9. doi: 10.14412/2074-2711-2024-4-85-89</mixed-citation><mixed-citation xml:lang="en">Kosivtsova OV, Starchina YuA, Urtenov KA, Belkina VV. Dizziness in elderly patients: discussion based on a clinical observation. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2024;16(4):85-9. doi: 10.14412/2074-2711-2024-4-85-89 (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Кулеш АА, Демин ДА, Гусева АЛ и др. Вестибулярное головокружение в неотложной неврологии. Российский неврологический журнал. 2021;26(4):50-9. doi: 10.30629/2658-7947-2021-26-4-50-59</mixed-citation><mixed-citation xml:lang="en">Kulesh AA, Dyomin DA, Guseva AL, et al. Vestibular vertigo in emergency neurology. Rossiyskiy nevrologicheskiy zhurnal = Russian Neurological Journal. 2021;26(4):50-9. doi: 10.30629/2658-7947-2021-26-4-50-59 (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Самородская ИВ, Андреев ЕМ, Заратьянц ОВ и др. Показатели смертности населения старше 50 лет от цереброваскулярных болезней за 15-летний период в России и США. Неврология, нейропсихиатрия, психосоматика. 2017;9(2):15-24. doi: 10.14412/2074-2711-2017-2-15-24</mixed-citation><mixed-citation xml:lang="en">Samorodskaya IV, Andreev EM, Zaratyants OV, et al. Cerebrovascular disease mortality rates in the population over 50 years of age in Russia and the USA over a 15-year period. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2017;9(2):15-24. doi: 10.14412/2074-2711-2017-2-15-24 (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Kroenke K, Hoffman RM, Einstadter D. How common are various causes of dizziness? A critical review. South Med J. 2000 Feb;93(2):160-7.</mixed-citation><mixed-citation xml:lang="en">Kroenke K, Hoffman RM, Einstadter D. How common are various causes of dizziness? A critical review. South Med J. 2000 Feb;93(2):160-7.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Косивцова ОВ, Яворская СА, Фатеева ТГ. Лечение вестибулярного головокружения у полиморбидного пациента. Неврология, нейропсихиатрия, психосоматика. 2018;10(1):96-101. doi: 10.14412/2074-2711-2018-1-96-101</mixed-citation><mixed-citation xml:lang="en">Kosivtsova OV, Yavorskaya SA, Fateeva TG. Vestibular vertigo treatment in a polymorbid patient. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2018;10(1):96-101. doi: 10.14412/2074-2711-2018-1-96-101 (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Lahmann C, Henningsen P, Brandt T, et al. Psychiatric comorbidity and psychosocial impairment among patients with vertigo and dizziness. J Neurol Neurosurg Psychiatry. 2015 Mar;86(3):302-8. doi: 10.1136/jnnp-2014-307601. Epub 2014 Jun 24.</mixed-citation><mixed-citation xml:lang="en">Lahmann C, Henningsen P, Brandt T, et al. Psychiatric comorbidity and psychosocial impairment among patients with vertigo and dizziness. J Neurol Neurosurg Psychiatry. 2015 Mar;86(3):302-8. doi: 10.1136/jnnp-2014-307601. Epub 2014 Jun 24.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Obermann M, Bock E, Sabev N, et al. Long-term outcome of vertigo and dizziness associated disorders following treatment in specialized tertiary care: the Dizziness and Vertigo Registry (DiVeR) Study. J Neurol. 2015 Sep;262(9):2083-91. doi: 10.1007/s00415-015-7803-7. Epub 2015 Jun 20.</mixed-citation><mixed-citation xml:lang="en">Obermann M, Bock E, Sabev N, et al. Long-term outcome of vertigo and dizziness associated disorders following treatment in specialized tertiary care: the Dizziness and Vertigo Registry (DiVeR) Study. J Neurol. 2015 Sep;262(9):2083-91. doi: 10.1007/s00415-015-7803-7. Epub 2015 Jun 20.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Cross-national comparisons of the prevalences and correlates of mental disorders. WHO International Consortium in Psychiatric Epidemiology. Bull World Health Organ. 2000;78(4):413-26.</mixed-citation><mixed-citation xml:lang="en">Cross-national comparisons of the prevalences and correlates of mental disorders. WHO International Consortium in Psychiatric Epidemiology. Bull World Health Organ. 2000;78(4):413-26.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Замерград МВ, Парфенов ВА, Остроумова ОД и др. Функциональное головокружение: от диагностических критериев к клиническим портретам и терапии. Согласованное мнение экспертов. Неврология, нейропсихиатрия, психосоматика. 2024;16(4):4-13. doi: 10.14412/2074-2711-2024-4-4-13</mixed-citation><mixed-citation xml:lang="en">Zamergrad MV, Parfenov VA, Ostroumova OD, et al. Functional dizziness: from diagnostic criteria to clinical profiles and therapy. Expert consensus. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2024;16(4):4- 13. doi: 10.14412/2074-2711-2024-4-4-13 (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Bittar RS, Dias von SЪhsten Lins EM. Clinical characteristics of patients with persistent postural-perceptual dizziness. Braz J Otorhinolaryngol. 2015 May-Jun;81(3):276-82. doi: 10.1016/j.bjorl.2014.08.012. Epub 2014 Sep 6.</mixed-citation><mixed-citation xml:lang="en">Bittar RS, Dias von SЪhsten Lins EM. Clinical characteristics of patients with persistent postural-perceptual dizziness. Braz J Otorhinolaryngol. 2015 May-Jun;81(3):276-82. doi: 10.1016/j.bjorl.2014.08.012. Epub 2014 Sep 6.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Застенская ЕН, Антоненко ЛМ. Коморбидные расстройства и терапия при персистирующем постуральном перцептивном головокружении. Неврология, нейропсихиатрия, психосоматика. 2023;15(4):66-73. doi: 10.14412/2074-2711-2023-466-73</mixed-citation><mixed-citation xml:lang="en">Zastenskaya EN, Antonenko LM. Comorbid disorders and therapy of persistent postural perceptual dizziness. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2023;15(4):66- 73. doi: 10.14412/2074-2711-2023-466-73 (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Cha YH, Brodsky J, Ishiyama G, et al. Clinical features and associated syndromes of mal de debarquement. J Neurol. 2008 Jul;255(7):1038-44. doi: 10.1007/s00415-008-0837-3. Epub 2008 May 30. 13. Yardley L. Overview of psychologic effects of chronic dizziness and balance disorders. Otolaryngol Clin North Am. 2000 Jun;33(3):603- 16. doi: 10.1016/s0030-6665(05)70229-2</mixed-citation><mixed-citation xml:lang="en">Cha YH, Brodsky J, Ishiyama G, et al. Clinical features and associated syndromes of mal de debarquement. J Neurol. 2008 Jul;255(7):1038-44. doi: 10.1007/s00415-008-0837-3. Epub 2008 May 30. 13. Yardley L. Overview of psychologic effects of chronic dizziness and balance disorders. Otolaryngol Clin North Am. 2000 Jun;33(3):603- 16. doi: 10.1016/s0030-6665(05)70229-2</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Borg-Stein J. Treatment of fibromyalgia, myofascial pain, and related disorders. Phys Med Rehabil Clin N Am. 2006 May;17(2):491- 510, viii. doi: 10.1016/j.pmr.2005.12.003</mixed-citation><mixed-citation xml:lang="en">Borg-Stein J. Treatment of fibromyalgia, myofascial pain, and related disorders. Phys Med Rehabil Clin N Am. 2006 May;17(2):491- 510, viii. doi: 10.1016/j.pmr.2005.12.003</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Антоненко ЛМ, Застенская ЕН. Персистирующее постурально-перцептивное головокружение: современные подходы к диагностике и лечению. Неврология, нейропсихиатрия, психосоматика. 2019;11(4):136-40. doi: 10.14412/2074-2711-2019-4-136-140</mixed-citation><mixed-citation xml:lang="en">Antonenko LM, Zastenskaya EN. Persistent postural-perceptual dizziness: current approaches to diagnosis and treatment. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2019;11(4):136-40. doi: 10.14412/2074-2711-2019-4-136-140 (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Heinrichs N, Edler C, Eskens S, et al. Predicting continued dizziness after an acute peripheral vestibular disorder. Psychosom Med. 2007 Sep-Oct;69(7):700-7. doi: 10.1097/PSY.0b013e318151a4dd. Epub 2007 Aug 31.</mixed-citation><mixed-citation xml:lang="en">Heinrichs N, Edler C, Eskens S, et al. Predicting continued dizziness after an acute peripheral vestibular disorder. Psychosom Med. 2007 Sep-Oct;69(7):700-7. doi: 10.1097/PSY.0b013e318151a4dd. Epub 2007 Aug 31.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Shih RD, Walsh B, Eskin B, et al. Diazepam and Meclizine Are Equally Effective in the Treatment of Vertigo: An Emergency Department Randomized Double-Blind Placebo-Controlled Trial. J Emerg Med. 2017 Jan;52(1):23-7. doi: 10.1016/j.jemermed.2016.09.016. Epub 2016 Oct 24.</mixed-citation><mixed-citation xml:lang="en">Shih RD, Walsh B, Eskin B, et al. Diazepam and Meclizine Are Equally Effective in the Treatment of Vertigo: An Emergency Department Randomized Double-Blind Placebo-Controlled Trial. J Emerg Med. 2017 Jan;52(1):23-7. doi: 10.1016/j.jemermed.2016.09.016. Epub 2016 Oct 24.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Marill KA, Walsh MJ, Nelson BK. Intravenous Lorazepam versus dimenhydrinate for treatment of vertigo in the emergency department: a randomized clinical trial. Ann Emerg Med. 2000 Oct;36(4):310-9. doi: 10.1067/mem.2000.110580</mixed-citation><mixed-citation xml:lang="en">Marill KA, Walsh MJ, Nelson BK. Intravenous Lorazepam versus dimenhydrinate for treatment of vertigo in the emergency department: a randomized clinical trial. Ann Emerg Med. 2000 Oct;36(4):310-9. doi: 10.1067/mem.2000.110580</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Pianese CP, Hidalgo LO, Gonzalez RH, et al. New approaches to the management of peripheral vertigo: efficacy and safety of two calcium antagonists in a 12-week, multinational, double-blind study. Otol Neurotol. 2002 May;23(3):357-63. doi: 10.1097/00129492-200205000-00023</mixed-citation><mixed-citation xml:lang="en">Pianese CP, Hidalgo LO, Gonzalez RH, et al. New approaches to the management of peripheral vertigo: efficacy and safety of two calcium antagonists in a 12-week, multinational, double-blind study. Otol Neurotol. 2002 May;23(3):357-63. doi: 10.1097/00129492-200205000-00023</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Cirek Z, Schwarz M, Baumann W, Novotny M. Efficacy and Tolerability of a Fixed Combination of Cinnarizine and Dimenhydrinate versus Betahistine in the Treatment of Otogenic Vertigo: A Double-Blind, Randomised Clinical Study. Clin Drug Investig. 2005;25(6):377-89. doi: 10.2165/00044011-200525060-00003</mixed-citation><mixed-citation xml:lang="en">Cirek Z, Schwarz M, Baumann W, Novotny M. Efficacy and Tolerability of a Fixed Combination of Cinnarizine and Dimenhydrinate versus Betahistine in the Treatment of Otogenic Vertigo: A Double-Blind, Randomised Clinical Study. Clin Drug Investig. 2005;25(6):377-89. doi: 10.2165/00044011-200525060-00003</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Hahn A, Sejna I, Stefflova B, et al. A fixed combination of cinnarizine/dimenhydrinate for the treatment of patients with acute vertigo due to vestibular disorders: a randomized, reference-controlled clinical study. Clin Drug Investig. 2008;28(2):89-99. doi: 10.2165/00044011-200828020-00003</mixed-citation><mixed-citation xml:lang="en">Hahn A, Sejna I, Stefflova B, et al. A fixed combination of cinnarizine/dimenhydrinate for the treatment of patients with acute vertigo due to vestibular disorders: a randomized, reference-controlled clinical study. Clin Drug Investig. 2008;28(2):89-99. doi: 10.2165/00044011-200828020-00003</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Helmchen C, Klinkenstein JC, Krüger A, et al. Structural brain changes following peripheral vestibulo-cochlear lesion may indicate multisensory compensation. J Neurol Neurosurg Psychiatry. 2011 Mar;82(3):309-16. doi: 10.1136/jnnp.2010.204925. Epub 2010 Aug 27.</mixed-citation><mixed-citation xml:lang="en">Helmchen C, Klinkenstein JC, Krüger A, et al. Structural brain changes following peripheral vestibulo-cochlear lesion may indicate multisensory compensation. J Neurol Neurosurg Psychiatry. 2011 Mar;82(3):309-16. doi: 10.1136/jnnp.2010.204925. Epub 2010 Aug 27.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">McDonnell MN, Hillier SL. Vestibular rehabilitation for unilateral peripheral vestibular dysfunction. Cochrane Database Syst Rev. 2015 Jan 13;1(1):CD005397. doi: 10.1002/14651858.CD005397.pub4</mixed-citation><mixed-citation xml:lang="en">McDonnell MN, Hillier SL. Vestibular rehabilitation for unilateral peripheral vestibular dysfunction. Cochrane Database Syst Rev. 2015 Jan 13;1(1):CD005397. doi: 10.1002/14651858.CD005397.pub4</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Иванова ГЕ, Кунельская НЛ, Парфенов ВА и др. Вестибулярная реабилитация в комплексной терапии вестибулярного головокружения (согласованное мнение экспертов). Неврология, нейропсихиатрия, психосоматика. 2024;16(1):114-21. doi: 10.14412/2074-2711-2024-1-114-121</mixed-citation><mixed-citation xml:lang="en">Ivanova GE, Kunelskaya NL, Parfenov VA, et al. Vestibular rehabilitation in complex therapy of vestibular vertigo (consensus of experts). Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2024;16(1):114-21. doi: 10.14412/2074-2711-2024-1-114-121 (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Yardley L, Beech S, Zander L, et al. A randomized controlled trial of exercise therapy for dizziness and vertigo in primary care. Br J Gen Pract. 1998 Apr;48(429):1136-40.</mixed-citation><mixed-citation xml:lang="en">Yardley L, Beech S, Zander L, et al. A randomized controlled trial of exercise therapy for dizziness and vertigo in primary care. Br J Gen Pract. 1998 Apr;48(429):1136-40.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Scholtz AW, Hahn A, Stefflova B, et al. Efficacy and Safety of a Fixed Combination of Cinnarizine 20 mg and Dimenhydrinate 40 mg vs Betahistine Dihydrochloride 16 mg in Patients with Peripheral Vestibular Vertigo: A Prospective, Multinational, Multicenter, Double-Blind, Randomized, Non-inferiority Clinical Trial. Clin Drug Investig. 2019 Nov;39(11):1045-56. doi: 10.1007/s40261-019-00858-6</mixed-citation><mixed-citation xml:lang="en">Scholtz AW, Hahn A, Stefflova B, et al. Efficacy and Safety of a Fixed Combination of Cinnarizine 20 mg and Dimenhydrinate 40 mg vs Betahistine Dihydrochloride 16 mg in Patients with Peripheral Vestibular Vertigo: A Prospective, Multinational, Multicenter, Double-Blind, Randomized, Non-inferiority Clinical Trial. Clin Drug Investig. 2019 Nov;39(11):1045-56. doi: 10.1007/s40261-019-00858-6</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Scholtz AW, Waldfahrer F, Hampel R, Weisshaar G. Efficacy and Safety of a FixedDose Combination of Cinnarizine 20 mg and Dimenhydrinate 40 mg in the Treatment of Patients with Vestibular Vertigo: An Individual Patient Data Meta-Analysis of Randomised, Double-Blind, Controlled Clinical Trials. Clin Drug Investig. 2022 Sep;42(9):705-20. doi: 10.1007/s40261-022-01184-0. Epub 2022 Jul 21.</mixed-citation><mixed-citation xml:lang="en">Scholtz AW, Waldfahrer F, Hampel R, Weisshaar G. Efficacy and Safety of a FixedDose Combination of Cinnarizine 20 mg and Dimenhydrinate 40 mg in the Treatment of Patients with Vestibular Vertigo: An Individual Patient Data Meta-Analysis of Randomised, Double-Blind, Controlled Clinical Trials. Clin Drug Investig. 2022 Sep;42(9):705-20. doi: 10.1007/s40261-022-01184-0. Epub 2022 Jul 21.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
